Ionis Pharmaceuticals, Inc. Sale and Leaseback Transaction, Gain (Loss), Net
Ionis Pharmaceuticals, Inc. (IONS) reported Sale and Leaseback Transaction, Gain (Loss), Net of $4.20 million for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-10-29.
Financial Statements › Income Statement › Other Income
us-gaap:SaleAndLeasebackTransactionGainLossNet · last filed 2026-02-26
- Ionis Pharmaceuticals, Inc. sale and leaseback transaction, gain (loss), net for the quarter ending 2022-12-31 was $150.10M.
- Ionis Pharmaceuticals, Inc. sale and leaseback transaction, gain (loss), net for fiscal 2024 was $0.00.
- Ionis Pharmaceuticals, Inc. sale and leaseback transaction, gain (loss), net for fiscal 2023 was -$161.00K, a 100.11% decline from fiscal 2022.
- Ionis Pharmaceuticals, Inc. sale and leaseback transaction, gain (loss), net for fiscal 2022 was $150.13M.
- Ionis Pharmaceuticals, Inc. sale and leaseback transaction, gain (loss), net for fiscal 2021 was $0.00.
| Period end | Sale and Leaseback Transaction, Gain (Loss), Net 1 month | Sale and Leaseback Transaction, Gain (Loss), Net 3 month | Sale and Leaseback Transaction, Gain (Loss), Net 9 month | Sale and Leaseback Transaction, Gain (Loss), Net 12 month |
|---|---|---|---|---|
| 2025-09-30 | $4.20M 10-K · filed 2026-02-26 | $4.20M 10-Q · filed 2025-10-29 | ||
| 2024-12-31 | $0.00 10-K · filed 2025-02-19 | |||
| 2023-12-31 | -$161.00K 10-K · filed 2025-02-19 | |||
| 2022-12-31 | $150.10M 10-K · filed 2024-02-21 | $150.13M 10-K · filed 2025-02-19 | ||
| 2021-12-31 | $0.00 10-K · filed 2024-02-21 | |||
| 2020-12-31 | $0.00 10-K · filed 2023-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |